Nanoparticle Platform for TB Vaccine Targeting Lymph Nodes
Melody Swartz and Jeffrey Hubbell of the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, will explore the use of a robust and inexpensive nanotechnology, which may penetrate lymph tissue to more effectively trigger immune responses, as a new tool for prevention of TB.